Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999–2006
- 3 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 30 (10), 1271-1278
- https://doi.org/10.1007/s10096-011-1223-0
Abstract
A total of 118 patients with Elizabethkingia meningoseptica bacteremia at a medical center in Taiwan from 1999 to 2006 were studied. Minimum inhibitory concentrations (MICs) of 99 preserved isolates were determined. The incidence (per 100,000 admissions) of E. meningoseptica bacteremia increased from 7.5 in 1996 to 35.6 in 2006 (p = 0.006). Among them, 84% presented with fever, 86% had nosocomial infections, and 60% had acquired the infection in intensive care units (ICUs). The most common underlying diseases were malignancy (36%) and diabetes mellitus (25%). Seventy-eight percent of patients had primary bacteremia, followed by pneumonia (9%), soft tissue infection, and catheter-related bacteremia (6%). Forty-five patients (38%) had polymicrobial bacteremia. Overall, the 14-day mortality was 23.4%. Multivariate analysis revealed E. meningoseptica bacteremia acquired in an ICU (p = 0.048, odds ratio [OR] 4.23) and presence of effective antibiotic treatment after the availability of culture results (p = 0.049, OR 0.31) were independent predictors of 14-day mortality. The 14-day mortality was higher among patients receiving carbapenems (p = 0.046) than fluoroquinolones or other antimicrobial agents. More than 80% of the isolates tested were susceptible to trimethoprim-sulfamethoxzole, moxifloxacin, and levofloxacin. The MIC50 and MIC90 of the isolates to tigecycline and doxycycline were both 4 μg/mL and 8 μg/ml, respectively.Keywords
This publication has 25 references indexed in Scilit:
- Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in TaiwanInternational Journal of Antimicrobial Agents, 2009
- RE: A novel bactericidal fabric coating with potent in vitro activity against meticillin-resistant Staphylococcus aureus (MRSA)International Journal of Antimicrobial Agents, 2009
- Predictive value of the serum bactericidal test for mortality in patients infected with multidrug-resistant Acinetobacter baumanniiJournal of Infection, 2007
- Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilliInternational Journal of Antimicrobial Agents, 2005
- Atypical Chryseobacterium meningosepticum and Meningitis and Sepsis in Newborns and the Immunocompromised, TaiwanEmerging Infectious Diseases, 2000
- A Flavobacterium meningosepticum outbreak among intensive care patientsAmerican Journal of Infection Control, 1993
- Respiratory infection caused by Flavobacterium meningosepticumThe Lancet, 1990
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- Flavobacterium meningosepticum bacteremia in an adult with acute leukemia use of rifampin to clear persistent infectionDiagnostic Microbiology and Infectious Disease, 1986
- Sphingobacterium gen. nov., Sphingobacterium spiritivorum comb. nov., Sphingobacterium multivorum comb. nov., Sphingobacterium mizutae sp. nov., and Flavobacterium indologenes sp. nov.: Glucose-Nonfermenting Gram-Negative Rods in CDC Groups IIK-2 and IIbInternational Journal of Systematic and Evolutionary Microbiology, 1983